Giannakis Lab Team
Marios Giannakis, M.D., Ph.D. - Principal Investigator
Dr. Giannakis is an Assistant Professor of Medicine at Harvard Medical School, a medical oncologist at the Gastrointestinal Cancer Center of the Dana-Farber Cancer Institute and an Associate Member at the Broad Institute of MIT and Harvard. His research focuses on understanding the pathogenesis, molecular epidemiology and tumor-immune microenvironment of colorectal cancer and translating these findings into novel targeted and immune-based therapies for patients.
Dr. Giannakis studied Molecular Genetics and Molecular Biology at the University of Toronto, obtained his M.D and Ph.D degree in Biology and Biomedical Sciences from Washington University in Saint Louis, completed his Internal Medicine residency at Brigham and Women's Hospital in Boston and was a hematology/oncology fellow at the Dana-Farber/Partners Cancer Care Program.
Dr. Giannakis is an Assistant Professor of Medicine at Harvard Medical School, a medical oncologist at the Gastrointestinal Cancer Center of the Dana-Farber Cancer Institute and an Associate Member at the Broad Institute of MIT and Harvard. His research focuses on understanding the pathogenesis, molecular epidemiology and tumor-immune microenvironment of colorectal cancer and translating these findings into novel targeted and immune-based therapies for patients.
Dr. Giannakis studied Molecular Genetics and Molecular Biology at the University of Toronto, obtained his M.D and Ph.D degree in Biology and Biomedical Sciences from Washington University in Saint Louis, completed his Internal Medicine residency at Brigham and Women's Hospital in Boston and was a hematology/oncology fellow at the Dana-Farber/Partners Cancer Care Program.
Lishan Fang, Ph.D.
Postdoctoral Fellow
Lishan is studying the biological functions of RNF43 in colorectal cancer by using organoid models and aims to discover better therapeutic strategies for patients whose tumors harbor RNF43 mutations.
Postdoctoral Fellow
Lishan is studying the biological functions of RNF43 in colorectal cancer by using organoid models and aims to discover better therapeutic strategies for patients whose tumors harbor RNF43 mutations.
Mansoureh Hakimi, Ph.D.
Postdoctoral Fellow
Mansoureh’s research focuses on establishing preclinical models of the colorectal tumor microenvironment. Her work could lead to novel predictive markers and immunotherapy combinations.
Postdoctoral Fellow
Mansoureh’s research focuses on establishing preclinical models of the colorectal tumor microenvironment. Her work could lead to novel predictive markers and immunotherapy combinations.
|
Casey O'Brien, B.Sc.
Research Associate Casey hopes to pursue a career in medicine and is interested in the relationship between tumors and the immune system. In her spare time she enjoys figure skating, reading, and painting. |
Carino Gurjao, M.Sc.
Bioinformatics Analyst
Paris-born and raised, Carino relocated to Boston in 2018 to join the Giannakis lab after having completed his M.Sc.Eng studies. He previously was a visiting student at MIT in 2016-2017. He is integrating sequencing data with clinical and epidemiological information such as lifestyle and diet habits in order to gain insights into novel prevention strategies and therapies for this disease.
Bioinformatics Analyst
Paris-born and raised, Carino relocated to Boston in 2018 to join the Giannakis lab after having completed his M.Sc.Eng studies. He previously was a visiting student at MIT in 2016-2017. He is integrating sequencing data with clinical and epidemiological information such as lifestyle and diet habits in order to gain insights into novel prevention strategies and therapies for this disease.